PCOS Rebranded: The Shift to Polyendocrine Metabolic Ovarian Syndrome
A New Diagnostic Era In a landmark decision announced on May 14, 2026, the international medical community, led by the Endocrine Society, officially renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This shift, impacting an estimated 170 million women globally, aims to address long-standing diagnostic inaccuracies and improve clinical care standards for…